Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 506

1.

Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.

Nakai Y, Tatsumi Y, Miyake M, Anai S, Masaomi K, Onishi S, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.

Photodiagnosis Photodyn Ther. 2015 Jul 27. pii: S1572-1000(15)30012-0. doi: 10.1016/j.pdpdt.2015.07.174. [Epub ahead of print] No abstract available.

PMID:
26226642
2.

Complementary Protein and Peptide OFFGEL Fractionation for High-Throughput Proteomic Analysis.

Magdeldin S, Elguoshy A, Yoshida Y, Hirao Y, Xu B, Zhang Y, Yamamoto K, Takimoto H, Fujinaka H, Kinoshita N, Yamamoto T.

Anal Chem. 2015 Jul 28. [Epub ahead of print]

PMID:
26168396
3.

Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo.

Sasahara K, Shimokawa Y, Hirao Y, Koyama N, Kitano K, Shibata M, Umehara K.

Drug Metab Dispos. 2015 Aug;43(8):1267-76. doi: 10.1124/dmd.115.064527. Epub 2015 Jun 8.

PMID:
26055620
4.

Frequency Extension to the THz Range in the High Pressure ESR System and Its Application to the Shastry-Sutherland Model Compound SrCu2(BO3)2.

Ohta H, Sakurai T, Matsui R, Kawasaki K, Hirao Y, Okubo S, Matsubayashi K, Uwatoko Y, Kudo K, Koike Y.

J Phys Chem B. 2015 May 26. [Epub ahead of print]

PMID:
26010675
5.

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy.

Tomioka A, Tanaka N, Yoshikawa M, Miyake M, Anai S, Chihara Y, Okajima E, Hirayama A, Hirao Y, Fujimoto K.

BMC Cancer. 2015 May 20;15:420. doi: 10.1186/s12885-015-1429-0.

6.

Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.

Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, Ozono S, Hara T, Matsuyama H, Oyama M, Ueno M, Fukuhara H, Narukawa M, Shuin T.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):193-200. doi: 10.1016/j.pdpdt.2015.03.008. Epub 2015 Apr 2.

PMID:
25843912
7.

Thiolate-bridged dinuclear ruthenium and iron complexes as robust and efficient catalysts toward oxidation of molecular dihydrogen in protic solvents.

Yuki M, Sakata K, Hirao Y, Nonoyama N, Nakajima K, Nishibayashi Y.

J Am Chem Soc. 2015 Apr 1;137(12):4173-82. doi: 10.1021/jacs.5b00584. Epub 2015 Mar 24.

PMID:
25756856
8.

A facile synthesis of trinaphtho[3.3.3]propellane and its π-extension and the formation of a two-dimensional honeycomb molecular assembly.

Kubo T, Miyazaki S, Kodama T, Aoba M, Hirao Y, Kurata H.

Chem Commun (Camb). 2015 Mar 4;51(18):3801-3. doi: 10.1039/c4cc09883h.

PMID:
25649894
9.

Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.

Nakai Y, Anai S, Onishi S, Masaomi K, Tatsumi Y, Miyake M, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):282-8. doi: 10.1016/j.pdpdt.2014.12.010. Epub 2015 Jan 13.

PMID:
25595357
10.

Isolation of a hydrogen-bonded complex based on the anthranol/anthroxyl pair: formation of a hydrogen-atom self-exchange system.

Hirao Y, Saito T, Kurata H, Kubo T.

Angew Chem Int Ed Engl. 2015 Feb 16;54(8):2402-5. doi: 10.1002/anie.201410796. Epub 2015 Jan 7.

PMID:
25565433
11.

Estimated functional renal parenchymal volume predicts the split renal function following renal surgery.

Mibu H, Tanaka N, Hosokawa Y, Kumamoto H, Margami N, Hirao Y, Fujimoto K.

World J Urol. 2015 Jan 3. [Epub ahead of print]

PMID:
25555568
12.

Synthesis of sexithiophene-bridged cage compound: a new class of three-dimensionally expanded oligothiophenes.

Adachi K, Hirao Y, Matsumoto K, Kubo T, Kurata H.

Org Lett. 2014 Nov 21;16(22):5870-3. doi: 10.1021/ol5027816. Epub 2014 Oct 31.

PMID:
25360898
13.

Glycoproteomics approach for identifying Glycobiomarker candidate molecules for tissue type classification of non-small cell lung carcinoma.

Hirao Y, Matsuzaki H, Iwaki J, Kuno A, Kaji H, Ohkura T, Togayachi A, Abe M, Nomura M, Noguchi M, Ikehara Y, Narimatsu H.

J Proteome Res. 2014 Nov 7;13(11):4705-16. doi: 10.1021/pr5006668. Epub 2014 Sep 22.

PMID:
25244057
14.

Design and synthesis of new stable fluorenyl-based radicals.

Tian Y, Uchida K, Kurata H, Hirao Y, Nishiuchi T, Kubo T.

J Am Chem Soc. 2014 Sep 10;136(36):12784-93. doi: 10.1021/ja507005c. Epub 2014 Aug 25.

PMID:
25134010
15.

Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan.

Onozawa M, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y, Akaza H.

Jpn J Clin Oncol. 2014 Oct;44(10):969-81. doi: 10.1093/jjco/hyu104. Epub 2014 Aug 6.

16.

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid.

Nakai Y, Anai S, Kuwada M, Miyake M, Chihara Y, Tanaka N, Hirayama A, Yoshida K, Hirao Y, Fujimoto K.

BMC Urol. 2014 Aug 3;14:59. doi: 10.1186/1471-2490-14-59.

17.

Enantioselective analysis of tolvaptan in rat and dog sera by high-performance liquid chromatography and application to pharmacokinetic study.

Furukawa M, Yamasaki Y, Hirao Y, Umehara K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 15;965:112-8. doi: 10.1016/j.jchromb.2014.06.007. Epub 2014 Jun 18.

PMID:
25016163
18.

Liquid chromatography-tandem mass spectrometry method for determining tolvaptan and its nine metabolites in rat serum: application to a pharmacokinetic study.

Furukawa M, Miyata K, Kawasome C, Himeda Y, Takeuchi K, Koga T, Hirao Y, Umehara K.

Arch Pharm Res. 2014 Dec;37(12):1578-87. doi: 10.1007/s12272-014-0352-2. Epub 2014 Mar 24.

PMID:
24988986
19.

Dual association modes of the 2,5,8-tris(pentafluorophenyl)phenalenyl radical.

Uchida K, Hirao Y, Kurata H, Kubo T, Hatano S, Inoue K.

Chem Asian J. 2014 Jul;9(7):1823-9. doi: 10.1002/asia.201402187. Epub 2014 May 9.

PMID:
24817683
20.

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer.

Tomioka A, Tanaka N, Yoshikawa M, Miyake M, Anai S, Chihara Y, Okajima E, Hirayama A, Hirao Y, Fujimoto K.

BMC Urol. 2014 Apr 29;14:33. doi: 10.1186/1471-2490-14-33.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk